These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 4059299)

  • 1. Preliminary human pharmacokinetics of triletide.
    Repossini L
    Pharmatherapeutica; 1985; 4(3 Spec No):189-94. PubMed ID: 4059299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing.
    Furr M; Kennedy T
    Vet Ther; 2000; 1(2):125-32. PubMed ID: 19757559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and biotransformation of the antiretroviral drug nevirapine in humans.
    Riska P; Lamson M; MacGregor T; Sabo J; Hattox S; Pav J; Keirns J
    Drug Metab Dispos; 1999 Aug; 27(8):895-901. PubMed ID: 10421616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cetirizine in healthy cats.
    Papich MG; Schooley EK; Reinero CR
    Am J Vet Res; 2008 May; 69(5):670-4. PubMed ID: 18447800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary pharmacokinetics of intravenous ciramadol in humans.
    Rosseel MT; Bogaert MG; Oosterlinck W
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):304-6. PubMed ID: 6547699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate (MN-1695), a new anti-ulcer agent.
    Nakashima M; Uematsu T; Takiguchi Y; Hayashi T
    Arzneimittelforschung; 1984; 34(4):492-8. PubMed ID: 6540108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of brodimoprim.
    Weidekamm E
    J Chemother; 1993 Dec; 5(6):475-9. PubMed ID: 8195840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and pharmacokinetic studies on Bamifylline. A review.
    Dodion L; Aylward M
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):204-10. PubMed ID: 552145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects.
    Cilla DD; Whitfield LR; Gibson DM; Sedman AJ; Posvar EL
    Clin Pharmacol Ther; 1996 Dec; 60(6):687-95. PubMed ID: 8988072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability and serum levels of benoxaprofen in healthy volunteers.
    Furlanut M; Montanari G; Colonna V; Perosa A
    Int J Clin Pharmacol Res; 1983; 3(3):163-6. PubMed ID: 6679519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose and steady-state pharmacokinetics of fentanyl buccal tablet in healthy volunteers.
    Darwish M; Kirby M; Robertson P; Hellriegel E; Jiang JG
    J Clin Pharmacol; 2007 Jan; 47(1):56-63. PubMed ID: 17192502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men.
    Kleinbloesem CH; Jaquet-Müller F; al-Hamdan Y; Baldauf C; Gisclon L; Wesnes K; Curtin CR; Stubbs RJ; Walker SA; Brunner-Ferber F
    Clin Pharmacol Ther; 1996 Jun; 59(6):675-85. PubMed ID: 8681493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals.
    Lakritz J; Wilson WD; Marsh AE; Mihalyi JE
    Vet Ther; 2002; 3(2):189-95. PubMed ID: 19750750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ethyl biscoumacetate and its metabolite 7-hydroxy ethyl biscoumacetate in healthy volunteers.
    Perlík F; Patzelová V
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):622-4. PubMed ID: 7874379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis and disposition of low dose oral propranolol.
    MacKichan JJ; Pyszczynski DR; Jusko WJ
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):531-8. PubMed ID: 674830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative determination of mefexamide and its main degradation product desmethyl-mefexamide in human urine after ingestion of therapeutic doses (author's transl)].
    Gielsdorf W; Herper M
    Z Rechtsmed; 1981; 87(4):297-303. PubMed ID: 7340287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.